Results 171 to 176 of about 52,363 (176)
Safety and immunogenicity of inactivated human Rotavirus vaccine in young children and infants: a randomized, placebo-controlled, double-blind, phase I clinical trial. [PDF]
Nat CommunZhou Y, Tan J, Liu Y, Pu J, Wu J, Liu X, Yi S, Hu X, Chen R, Ye J, Yin N, Lin X, Gao J, Tong Q, Kuang X, Yang Y, Zhang W, Wang Y, Sun M, Zhang G, Wang Y, Yang J, Hu Z, Li H. +23 moreeuropepmc +1 more sourceEvaluation of false positive enteric viruses results from the BIOFIRE® FILMARRAY® gastrointestinal PCR panel. [PDF]
J Clin VirolChhabra P, Cates J, Bartlett E, Embury SA, Rizwan A, Williams FA, Kambhampati AK, Marconi VC, Epstein L, Jasarevic R, Kraft CS, Rodriguez-Barradas MC, Morones RG, Covarrubias MA, Beenhouwer DO, Goldin E, Brown ST, Pena I, Lucero-Obusan CA, Holodniy M, Gautam R, Mirza SA, Vinjé J, Surveillance Platform for Enteric and Respiratory Infectious Organisms at the VA (SUPERNOVA) AGE Surveillance Group. +23 moreeuropepmc +1 more sourceGenomic epidemiology reveals post-vaccine re-emergence of vaccine-associated G1P[8] rotavirus lineages with variable disease severity
Mhango C, Chinyama E, Banda A, Wachepa R, Gauti L, Matambo E, Kawonga F, Ndovie W, Chaima D, Zuza A, Kalizang’oma A, Mhango M, Cunliffe NA, Tshiswaka NJ, Mogotsi MT, Ogunbayo AE, Dennis FE, Nyaga MM, Kumwenda B, Donato CM, Kamng’ona AW, Chaguza C, Jere KC. +22 moreeuropepmc +1 more source